HIVR4P 2024, the 5th HIV Research for Prevention Conference, is just 11 days away! Take a look at some of the late-breaking science you can expect to see at the only global scientific conference focused exclusively on the challenging and fast-growing field of HIV prevention research.

HIVR4P 2024 will take place in Lima, Peru, and virtually, from 6 to 10 October 2024.

Late-breaking HIV prevention scientific highlights to expect at HIVR4P 2024:

  • Evidence that the three-month dapivirine vaginal ring (100 mg) is pharmacokinetically superior to the monthly dapivirine vaginal ring (25 mg)
  • Preclinical data on a drug-agnostic transcutaneously-refillable subdermal implant for ultra-long-acting delivery of antiretrovirals for HIV prevention 
  • Data from the SAMURAI study on the acceptability, adherence, preference and safety of placebo long-acting PrEP injections and implants for men in South Africa
  • Insights from early implementation of long-acting injectable cabotegravir for HIV prevention in a safety net primary care center in the southern United States
  • Findings from South Africa on the use of rapid HIV tests when initiating long-acting cabotegravir for HIV prevention